Cited by 81Parkinson's Disease Mechanisms and TreatmentsMicroRNA in disease regulationNuclear Receptors and Signaling

Parkinson's disease: SNCA-, PARK2-, and LRRK2- targeting microRNAs elevated in cingulate gyrus

Tatura, Roman, Kraus, Theo, Giese, Armin, Arzberger, Thomas, Buchholz, Malte, Höglinger, Günter, Müller, Ulrich·2016·Parkinsonism & Related Disorders

Abstract

Introduction In order to better understand the role of epigenetic influences in the etiology of Parkinson's disease (PD), we studied the expression of microRNAs in gyri cinguli of patients and controls. Methods Expression profiling of 744 well-characterized microRNAs in gyri cinguli from patients and controls using TaqMan array microRNA cards. Verification of significantly dysregulated microRNAs by SYBR Green qRT-PCR. Results First screen by TaqMan array identified 43 microRNAs that were upregulated in gyri cinguli from patients. Of those microRNAs, 13 are predicted to regulate at least one of six genes mutated in monogenic forms of PD (DJ-1, PARK2, PINK1, LRRK2, SNCA, and HTRA2). Five of these 13 microRNAs (-144, -199b, -221, -488, -544) were also found upregulated by SYBR Green qRT-PCR and are predicted to regulate either SNCA, PARK2, LRRK2 or combinations thereof. Consistently, expression of SNCA, PARK2, and LRRK2 was reduced in patients. An additional 5 out of ten potential target genes tested were downregulated. These are DRAM (DNA damage regulated autophagy modulator 1), predicted to be regulated by miR-144, EVC (Ellis Van Creveld Protein) by miR-221, ZNF440 (Zinc Finger Protein 440) by miR-199b, MTFMT (Mitochondrial Methionyl-tRNA Formyltransferase) by miR-488 and XIRP2 (Xin Actin Binding Repeat Containing) possibly controlled by miR-544a. Conclusion The study identified five microRNAs that play a role in the etiology of Parkinson's disease likely by modifying expressi…

Integrity signals

Registry

Crossref · 10.1016/j.parkreldis.2016.09.028

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • miR-29 and five other miRNAs (miR-26, miR-30, miR-199b, miR-212, miR-380-5p) are upregulated in sporadic human PD brain.

    “Out of the 81 miRNAs that inhibited PRKN translocation in our screen, miR-29 and five other miRNAs (miR-26 and miR-30, miR-199b, miR-212, miR-380-5p) have been reported to be upregulated in sporadic human PD brain [40–42].”

    From miRNA family miR-29 inhibits PINK1-PRKN signaling via ATG9A (2026) · cites this paper as [40]

The citation lists haven’t been fetched yet

References 30 · Cited by 81

Authors
Tatura, R., Kraus, T., Giese, A., Arzberger, T., Buchholz, M., Höglinger, G., & Müller, U.
Affiliations
  • Justus-Liebig-Universität Gießen (DE)
  • Institut für Neuropathologie (DE)
  • Philipps University of Marburg (DE)
  • German Center for Neurodegenerative Diseases (DE)
Corresponding author
Müller, Ulrich
Venue
Parkinsonism & Related Disorders
Publisher
Elsevier BV
Published
2016-12
Volume
33
Pages
115-121
ISSN
1353-8020 (ISSN-L)
OpenAlex
W2523996467
Cited by
81
References
30
Citations by year
2026: 3 · 2025: 3 · 2024: 10 · 2023: 12 · 2022: 17 · 2021: 9 · 2020: 5 · 2019: 9 · 2018: 6 · 2017: 5 · 2016: 1
FWCI
5.26
Type
journal article
Language
en
Open access
closed
Locations
  • Parkinsonism & Related Disorders (publishedVersion)
  • PubMed (publishedVersion)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
  • DZNE Pub (submittedVersion)
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
Keywords
Parkinson's disease, microRNA
MeSH terms
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Aged, Female, Gene Expression Regulation, Gyrus Cinguli, Humans, Male, Middle Aged, Parkinson Disease, MicroRNAs, Ubiquitin-Protein Ligases, alpha-Synuclein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review